We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Novacyt S.a. | LSE:NCYT | London | Ordinary Share | FR0010397232 | EUR1/15TH (CDI) |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -1.60 | -3.11% | 49.90 | 153,374 | 16:35:18 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 48.80 | 51.00 | 53.00 | 48.90 | 53.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| In Vitro,in Vivo Diagnostics | 11.58M | -28.29M | - | - | 36.37M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:23:15 | O | 270 | 49.0376 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 25/7/2024 | 07:00 | UK RNS | Novacyt S.A. Half Year Trading Update |
| 18/7/2024 | 16:00 | UK RNS | Novacyt S.A. Result of AGM |
| 18/7/2024 | 07:00 | UK RNS | Novacyt S.A. AGM Statement on Impact of DHSC Settlement |
| 01/7/2024 | 15:45 | UK RNS | Novacyt S.A. Liquidity Agreement and Total Voting Rights |
| 26/6/2024 | 14:30 | UK RNS | Novacyt S.A. Notice of rescheduled AGM |
| 14/6/2024 | 07:00 | UK RNS | Novacyt S.A. Publication of Annual Report |
| 11/6/2024 | 07:00 | UK RNS | Novacyt S.A. Settlement of the dispute with the DHSC |
| 03/6/2024 | 13:00 | UK RNS | Novacyt S.A. Liquidity Agreement and Total Voting Rights |
| 03/6/2024 | 07:00 | UK RNS | Novacyt S.A. AGM voting |
| 30/5/2024 | 07:00 | UK RNS | Novacyt S.A. Final Results |
Novacyt (NCYT) Share Charts1 Year Novacyt Chart |
|
1 Month Novacyt Chart |
Intraday Novacyt Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/7/2024 | 17:30 | COVID-19 | 68,568 |
| 07/10/2023 | 12:26 | NCYT million's | 125 |
| 29/7/2023 | 23:42 | black cloud | 139 |
| 07/12/2022 | 12:18 | sold millions | 19 |
| 06/9/2022 | 13:15 | coronavirusTransmission facts vs fiction | 505 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-07-26 15:23:16 | 49.04 | 270 | 132.40 | O |
| 2024-07-26 15:11:23 | 49.74 | 600 | 298.44 | O |
| 2024-07-26 14:42:28 | 48.00 | 5 | 2.40 | O |
| 2024-07-26 14:42:28 | 48.90 | 2,957 | 1,445.97 | AT |
| 2024-07-26 14:42:28 | 48.90 | 7,500 | 3,667.50 | AT |
| Top Posts |
|---|
Posted at 26/7/2024 09:20 by Novacyt Daily Update Novacyt S.a. is listed in the In Vitro,in Vivo Diagnostics sector of the London Stock Exchange with ticker NCYT. The last closing price for Novacyt was 51.50p.Novacyt currently has 70,626,248 shares in issue. The market capitalisation of Novacyt is -. This morning NCYT shares opened at 53p |
Posted at 20/6/2024 23:41 by dudishes Not followed for a couple of weeks, but notice my short at 68 has gathered pace.Where are we now? Original price of 10p or less? No word on current case, but then, who would bother to attend? |
Posted at 18/6/2024 20:11 by criticalthinker1 In the autumn [of 2020],” Cummings said in his written statement, “Sunak’s team supported me with the mass testing team as we tried to overcome horrific Whitehall bureaucracy, secretly buy hundreds of millions of fast tests before other countries realised their value and there was a PPE-like panic.”The UK Health Security Agency has confirmed in response to a freedom of information request that the “secret” buying of tests was the first contract awarded to Innova. Agreed in September 2020, it was worth £103m. The government went on to spend billions more with the company. The information raises further questions about the UK government’s widely criticised decision-making during the pandemic, and the huge sums of public money spent after normal procurement processes were suspended. The apparent support of Sunak’s team also raises questions about how far the Treasury was involved in the government expenditure of billions of pounds on test and trace and personal protective equipment. Sunak has repeatedly presented his work during the pandemic as a landmark success, telling workers at an event on the first day of the 2024 general election campaign: “You know you can trust me when it comes to the economy: I got our country through Covid.” ‘Risks to value for money’ For Innova, landing any UK government contracts at all was an extraordinary bonanza. The company was only formed in March 2020 by Huang’s California-based financial vehicle Pasaca Capital Inc, said by some of its own investors in the legal claims to have had little money behind it. Huang, a serial entrepreneur, had limited evident success in his track record, according to the legal claims against him. After the pandemic hit, everything changed. Another investor in Pasaca had a connection with a company in China, Xiamen Biotime Biotechnology, which like many others around the world, including some in the same city of Xiamen, was beginning to manufacture LFT kits. Kimberley Thonger, Innova’s UK representative, who had previously worked in marketing for a series of shoe companies including Dr Martens, emailed Cummings in Downing Street in July 2020. In that email, published following a freedom of information request by the Good Law Project, Thonger promised that the tests were “a true gamechanger”. Cummings told the Covid inquiry he saw the rapid tests as key to the proposed mass daily testing that he believed could enable “superspreader The authorisation was based on tests carried out at the government’s high-security Porton Down laboratory, which had been asked to evaluate a number of LFTs and indicated that it had prioritised Innova’s product because contracts had already been awarded to the company. The Department of Health and Social Care identified Innova at that time as the only supplier with a validated test that could produce the large volumes needed and work flexibly. A worker in PPE processing a lateral flow test A worker processing an Innova lateral flow test at Hull University in January 2021. Photograph: Paul Ellis/AFP/Getty Images By March 2021, Innova had already been awarded contracts worth £3.2bn, according to a critical National Audit Office report published in June of that year. The public spending watchdog noted that Innova was still “the only supplier of LFDs [lateral flow devices] for self-test approved by the MHRA”. The report warned that there were “risks to value for money due to a lack of competition and normal regulatory processes”. Cummings said the government needed to buy these tests secretly, “without alerting the rest of the world”. But countries across Europe were already evaluating rapid tests, and Italy was using them in ports and airports from the summer of 2020. In September 2020, the World Health Organization issued guidance, noting that nearly 100 companies were developing or manufacturing rapid tests. It announced a “global partnership” to supply 120m kits to poorer countries, made by companies in the US and South Korea. In February 2021, the EU published a list of 82 different suppliers, but not including Innova or Xiamen Biotime Biotechnology. Innova did offer to sell to other countries, but does not appear to have done so in large quantities. In a scathing report published after Innova first distributed them in the US without authorisation, the Food and Drug Administration (FDA) said the tests should be thrown away or returned to the company. It has repeatedly barred attempts to import the tests. An FDA spokesperson said: “Covid-19 antigen tests produced by Xiamen Biotime Biotechnology Company are being refused admission into the US.” Innova was included in a later edition of the EU’s approved list, among many other manufacturers, as a “B” supplier; member states were advised to use tests from the “A” list. Robert Kasprzak. Photograph: Innova Medical Group The UK government is said to have ordered 1.8bn tests from Innova altogether, paying the company approximately £4.3bn. In one of the legal claims against Huang, the former Innova executive Robert Kasprzak states: “Innova’ In 2022, Huang was featured in a film, Asian Inspirations, saying Innova had made a profit of $2bn after tax from its Covid contracts. Huang is now contesting legal claims over those profits, from Kasprzak and Innova’s UK representatives, Thonger and Charles Palmer, claiming they should have been paid more. Kasprzak accuses Huang of having a chequered career and few achievements of substance before Innova’s remarkable fortunes in the pandemic. Huang is accused in the claim of being “a high-end con artist” who squandered or moved for his own use due to “incompetence, power and greed … more than $1bn of … assets generated from UK sales”. He is alleged to have lavished some of the proceeds on luxury purchases including private jets for $70m, the $18m luxury home with a swimming pool in LA known as “the CEO house”, and “homes for his mistresses”, as well as poor investments in “flailing businesses”. Kasprzak also claims Huang was trying to secure a knighthood and working on having a film made about himself, titled Overnight Billionaire. He alleges Huang promised to buy out his shares for $75m but never did, and ultimately fired him from the company. Huang has responded by denying the claims and alleging that Kasprzak and the former Innova chief executive Daniel Elliott “stole” millions from the company. Kasprzak and Elliott deny those allegations. The UK representatives, Thonger and Palmer, are also suing Innova in California, claiming that their company, Disruptive Nanotechnology, was due 10% commission on all UK contracts, and so they should have been paid $500m. They accuse Kasprzak and Elliott of duping them out of that commission and pocketing the money themselves. Instead of the saved commissions being used for the promised purpose, “to keep the price of Innova’s Covid-19 tests competitive”, the claim alleges, Elliott “spent tens of millions of dollars to purchase lavish properties, expensive cars, a private jet, and other luxury items”. They both deny those claims. The disputes are all ongoing. Whatever the merits of their arguments, this fight on the US west coast is over extraordinarily large amounts of British taxpayers’ money, spent during the pandemic, with one newly formed company, for vast quantities of rapid Covid tests that it was able to deliver. A spokesperson for Innova and Huang dismissed the allegations against him as “baseless̶ Mark Holscher, a Los Angeles attorney representing Elliott, said he “categorically denies” any claims against him, and “did not receive any improper compensation” from anybody. “These tests saved thousands of British lives and prevented many more hospitalisations, An attorney representing Kasprzak said he “stands by” his legal claims, and added: “None of these US proceedings has called into question the efficacy of the tests or the UK government process. The tests saved thousands of British lives, as recognised by the UK government itself, and Mr Kasprzak is extremely proud of his role in delivering these tests to the UK.” A spokesperson for Disruptive Nanotechnology said: “We cannot comment on ongoing legal proceedings.” Cummings did not respond to requests for comment. A government spokesperson said in a statement given before the general election was called: “We have always said there are lessons to be learned from the pandemic and we are committed to learning from the Covid inquiry’s findings which will play a key role in informing the government’s planning and preparations for the future. While the inquiry is ongoing, it would not be appropriate to comment.” The Covid inquiry is due in the spring to turn its attention to the government’s multibillion-pound spending on medical supplies, including lateral flow tests, in the extraordinary circumstances of the pandemic. The con continues. |
Posted at 14/6/2024 21:10 by wad collector Blackhorse , you have forgotten that you already claimed several occasions to have sold out here and bought APH but never claim to have bought any here. Not that I am questioning your honesty of course...Blackhorse23 - 14 Jun 2024 - 08:37:45 - 68536 of 68540 COVID-19 - NCYT Out from here & bought APH Blackhorse23 - 30 May 2024 - 10:42:09 - 68476 of 68540 COVID-19 - NCYT Money moving to APH ( alliance pharma ) Blackhorse23 - 18 Apr 2024 - 10:22:48 - 68397 of 68540 COVID-19 - NCYT AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders -DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION Blackhorse23 - 21 Feb 2024 - 15:29:50 - 68371 of 68540 COVID-19 - NCYT Money moving to APH , excellent growth health care company Blackhorse23 - 29 Jan 2024 - 15:32:53 - 68369 of 68540 COVID-19 - NCYT Blackhorse23 - 16 Jan 2024 - 15:39:29 - 68362 of 68540 COVID-19 - NCYT Out from here & reinvested in APH Blackhorse23 - 28 Nov 2023 - 09:47:03 - 68342 of 68540 COVID-19 - NCYT Money moving to APH Blackhorse23 - 23 Nov 2023 - 10:12:40 - 68331 of 68540 COVID-19 - NCYT Switched to APH Blackhorse23 - 09 Nov 2023 - 11:35:09 - 68326 of 68540 COVID-19 - NCYT Blackhorse23 - 07 Nov 2023 - 09:10:12 - 68315 of 68540 COVID-19 - NCYT Money moving to APH , out from profit & going to buy A |
Posted at 11/6/2024 08:10 by the_mandalorian I can't belive that people on here thought this case was about NCYT getting cash, that was never going to happen.The fact they got off with paying £5 million rather than £121 million is a cracking result cash was £40 mill recently add to the business and I believe the market cap today is about £38 million & 55p??? . |
Posted at 11/6/2024 07:53 by the_mandalorian it is only right that the man who broke the DHSC news originally returned to the thread to stand over their victory,So here i am! ;) NCYT looks to have a lucky escape, IMHO every single penny of tax payer cash should have been taken from these covid grifters. A decent results for ncyt. DHSC WIN As Tammyrimerman said for years, NCYT will win t with no problem.LOL Oh he also thought TNT was another safe bet, but wound up last week. The mando hates being the big noise. |
Posted at 11/6/2024 07:31 by s34icknote So dec 2023 44 milllion left .Cash burn ? Yourgene lost 6.7 million last year ? Ncyt losses ? |
Posted at 10/6/2024 16:06 by goldie40 interesting first day of the court case and the share price goes up do the lawyers no something perhaps out of court settlement ? |
Posted at 05/6/2024 18:13 by andymunchkin bobaxe1 - 14 Jan 2021 - 11:23:40 - 45750 of 68478 COVID-19 - NCYTSo vaccine gives you immunity for 5 months which means covid is endemic translates to testing is here to stay this company will now grow & GROW not selling ever !// ----- bobaxe1 - 15 Jan 2021 - 12:52:24 - 45835 of 68478 COVID-19 - NCYT 50 million tests to one government gives us a share price of 30 quid. Did anyone see that mind blowing ----- bobaxe1 - 15 Jan 2021 - 14:32:59 - 45841 of 68478 COVID-19 - NCYT Forgot 30quid valuation.... ------ bOObs U nEEd tO tOpUp prOntO |
Posted at 01/5/2024 13:43 by andymunchkin robertbarns127 Apr '24 - 01:19 - 68428 of 684370 0 3 if we lose in court what do investors think will happen to the share price ... 40p , 30p , 20p or 10p possible --- id gO fEr thE mIddle gROUnd. 2op saFEr bEt |
Posted at 27/4/2024 01:19 by robertbarns1 if we lose in court what do investors think will happen to the share price ... 40p , 30p , 20p or 10p possible |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
